|
NL154600B
(en)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
|
|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US3715345A
(en)
|
1970-08-03 |
1973-02-06 |
Lilly Co Eli |
Glucagon separation process
|
|
NL154598B
(en)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
|
|
NL154599B
(en)
|
1970-12-28 |
1977-09-15 |
Organon Nv |
PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
|
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
|
US3867517A
(en)
|
1971-12-21 |
1975-02-18 |
Abbott Lab |
Direct radioimmunoassay for antigens and their antibodies
|
|
NL171930C
(en)
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
|
|
US3850578A
(en)
|
1973-03-12 |
1974-11-26 |
H Mcconnell |
Process for assaying for biologically active molecules
|
|
US3876623A
(en)
|
1973-05-09 |
1975-04-08 |
Lilly Co Eli |
Process for purifying insulin
|
|
US3863008A
(en)
|
1973-06-11 |
1975-01-28 |
American Home Prod |
Somatostatin as stimulant of luteinizing hormone secretion
|
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4034074A
(en)
|
1974-09-19 |
1977-07-05 |
The Board Of Trustees Of Leland Stanford Junior University |
Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
|
|
US3984533A
(en)
|
1975-11-13 |
1976-10-05 |
General Electric Company |
Electrophoretic method of detecting antigen-antibody reaction
|
|
US4036945A
(en)
|
1976-05-03 |
1977-07-19 |
The Massachusetts General Hospital |
Composition and method for determining the size and location of myocardial infarcts
|
|
US4098876A
(en)
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4879219A
(en)
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
|
US4476301A
(en)
|
1982-04-29 |
1984-10-09 |
Centre National De La Recherche Scientifique |
Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon
|
|
US4687808A
(en)
|
1982-08-12 |
1987-08-18 |
Biospecific Technologies, Inc. |
Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
|
|
IL68218A
(en)
|
1983-03-23 |
1985-12-31 |
Univ Ramot |
Compositions for cartilage repair comprising embryonal chondrocytes
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5011771A
(en)
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
|
US5550111A
(en)
|
1984-07-11 |
1996-08-27 |
Temple University-Of The Commonwealth System Of Higher Education |
Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US5235033A
(en)
|
1985-03-15 |
1993-08-10 |
Anti-Gene Development Group |
Alpha-morpholino ribonucleoside derivatives and polymers thereof
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5405938A
(en)
|
1989-12-20 |
1995-04-11 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
DE3681787D1
(en)
|
1985-07-05 |
1991-11-07 |
Whitehead Biomedical Inst |
EXPRESSION OF FOREIGN GENETIC MATERIAL IN EPITHELIC CELLS.
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
GB8606913D0
(en)
|
1986-03-20 |
1986-04-23 |
Hider R C |
Treatment of sickle cell disease
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
EP0260032B1
(en)
|
1986-09-08 |
1994-01-26 |
Ajinomoto Co., Inc. |
Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers
|
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
US5276019A
(en)
|
1987-03-25 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
US5166320A
(en)
|
1987-04-22 |
1992-11-24 |
University Of Connecticut |
Carrier system and method for the introduction of genes into mammalian cells
|
|
US4806484A
(en)
|
1987-08-07 |
1989-02-21 |
Igb Products, Ltd. |
Perfusion airlift bioreactor
|
|
EP0378576B1
(en)
|
1987-09-11 |
1995-01-18 |
Whitehead Institute For Biomedical Research |
Transduced fibroblasts and uses therefor
|
|
US5188897A
(en)
|
1987-10-22 |
1993-02-23 |
Temple University Of The Commonwealth System Of Higher Education |
Encapsulated 2',5'-phosphorothioate oligoadenylates
|
|
US4924624A
(en)
|
1987-10-22 |
1990-05-15 |
Temple University-Of The Commonwealth System Of Higher Education |
2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
|
|
DE3855864T2
(en)
|
1987-11-30 |
1997-09-25 |
Univ Iowa Res Found |
DNA MOLECULES STABILIZED BY MODIFICATIONS ON THE 3'-TERMINAL PHOSPHODIESTERBINDING, THEIR USE AS NUCLEIC ACID PROBE AND AS A THERAPEUTIC AGENT FOR INHIBITING THE EXPRESSION OF SPECIFIC TARGET GENES
|
|
US5403711A
(en)
|
1987-11-30 |
1995-04-04 |
University Of Iowa Research Foundation |
Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved
|
|
ATE110108T1
(en)
|
1987-12-11 |
1994-09-15 |
Whitehead Biomedical Inst |
GENETIC MODIFICATION OF ENDOTHELIAL CELLS.
|
|
JP2917998B2
(en)
|
1988-02-05 |
1999-07-12 |
ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ |
Modified hepatocytes and their uses
|
|
JPH01222780A
(en)
|
1988-03-02 |
1989-09-06 |
Tosoh Corp |
Method for refolding urokinase precursor-like protein
|
|
EP0406309A4
(en)
|
1988-03-25 |
1992-08-19 |
The University Of Virginia Alumni Patents Foundation |
Oligonucleotide n-alkylphosphoramidates
|
|
US5081035A
(en)
|
1988-04-18 |
1992-01-14 |
The University Of Michigan |
Bioreactor system
|
|
US5278302A
(en)
|
1988-05-26 |
1994-01-11 |
University Patents, Inc. |
Polynucleotide phosphorodithioates
|
|
US5216141A
(en)
|
1988-06-06 |
1993-06-01 |
Benner Steven A |
Oligonucleotide analogs containing sulfur linkages
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5256775A
(en)
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
|
US5399493A
(en)
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5437994A
(en)
|
1989-06-15 |
1995-08-01 |
Regents Of The University Of Michigan |
Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5399676A
(en)
|
1989-10-23 |
1995-03-21 |
Gilead Sciences |
Oligonucleotides with inverted polarity
|
|
US5264562A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences, Inc. |
Oligonucleotide analogs with novel linkages
|
|
US5264564A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences |
Oligonucleotide analogs with novel linkages
|
|
US5177198A
(en)
|
1989-11-30 |
1993-01-05 |
University Of N.C. At Chapel Hill |
Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
|
|
US5623065A
(en)
|
1990-08-13 |
1997-04-22 |
Isis Pharmaceuticals, Inc. |
Gapped 2' modified oligonucleotides
|
|
US5587361A
(en)
|
1991-10-15 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having phosphorothioate linkages of high chiral purity
|
|
US5220007A
(en)
|
1990-02-15 |
1993-06-15 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of RNA and production of encoded polypeptides
|
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
|
US5321131A
(en)
|
1990-03-08 |
1994-06-14 |
Hybridon, Inc. |
Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling
|
|
US5470967A
(en)
|
1990-04-10 |
1995-11-28 |
The Dupont Merck Pharmaceutical Company |
Oligonucleotide analogs with sulfamate linkages
|
|
US5612211A
(en)
|
1990-06-08 |
1997-03-18 |
New York University |
Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
|
|
US6326198B1
(en)
|
1990-06-14 |
2001-12-04 |
Regents Of The University Of Michigan |
Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
|
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
|
US5623070A
(en)
|
1990-07-27 |
1997-04-22 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
|
US5541307A
(en)
|
1990-07-27 |
1996-07-30 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs and solid phase synthesis thereof
|
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
|
US5618704A
(en)
|
1990-07-27 |
1997-04-08 |
Isis Pharmacueticals, Inc. |
Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
|
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
|
KR100211552B1
(en)
|
1990-08-03 |
1999-08-02 |
디. 꼬쉬 |
Compounds and methods for inhibiting gene expression
|
|
US5177196A
(en)
|
1990-08-16 |
1993-01-05 |
Microprobe Corporation |
Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
|
|
KR100272077B1
(en)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5214134A
(en)
|
1990-09-12 |
1993-05-25 |
Sterling Winthrop Inc. |
Process of linking nucleosides with a siloxane bridge
|
|
US5561225A
(en)
|
1990-09-19 |
1996-10-01 |
Southern Research Institute |
Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages
|
|
US5596086A
(en)
|
1990-09-20 |
1997-01-21 |
Gilead Sciences, Inc. |
Modified internucleoside linkages having one nitrogen and two carbon atoms
|
|
JP3249516B2
(en)
|
1990-10-31 |
2002-01-21 |
ソマティクス セラピー コーポレイション |
Retroviral vectors for gene therapy
|
|
US5486359A
(en)
|
1990-11-16 |
1996-01-23 |
Osiris Therapeutics, Inc. |
Human mesenchymal stem cells
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
|
US5851832A
(en)
|
1991-07-08 |
1998-12-22 |
Neurospheres, Ltd. |
In vitro growth and proliferation of multipotent neural stem cells and their progeny
|
|
US5571799A
(en)
|
1991-08-12 |
1996-11-05 |
Basco, Ltd. |
(2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
|
|
WO1993009220A1
(en)
|
1991-11-06 |
1993-05-13 |
Correa Paulo N |
Cell culture medium
|
|
US5700922A
(en)
|
1991-12-24 |
1997-12-23 |
Isis Pharmaceuticals, Inc. |
PNA-DNA-PNA chimeric macromolecules
|
|
EP0629236B1
(en)
|
1992-03-04 |
2002-10-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietic cells
|
|
US5792751A
(en)
|
1992-04-13 |
1998-08-11 |
Baylor College Of Medicine |
Tranformation of cells associated with fluid spaces
|
|
US5633360A
(en)
|
1992-04-14 |
1997-05-27 |
Gilead Sciences, Inc. |
Oligonucleotide analogs capable of passive cell membrane permeation
|
|
US5434257A
(en)
|
1992-06-01 |
1995-07-18 |
Gilead Sciences, Inc. |
Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
|
|
US5281521A
(en)
|
1992-07-20 |
1994-01-25 |
The Trustees Of The University Of Pennsylvania |
Modified avidin-biotin technique
|
|
US5652355A
(en)
|
1992-07-23 |
1997-07-29 |
Worcester Foundation For Experimental Biology |
Hybrid oligonucleotide phosphorothioates
|
|
US5320963A
(en)
|
1992-11-25 |
1994-06-14 |
National Research Council Of Canada |
Bioreactor for the perfusion culture of cells
|
|
US5476925A
(en)
|
1993-02-01 |
1995-12-19 |
Northwestern University |
Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
|
|
CA2155515A1
(en)
|
1993-02-19 |
1994-09-01 |
Wendy Waegell |
Expansion of stem cells in long term bone marrow cultures by neutralization of tgf-.beta.
|
|
US5654186A
(en)
|
1993-02-26 |
1997-08-05 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
GB9304618D0
(en)
|
1993-03-06 |
1993-04-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
WO1994022891A1
(en)
|
1993-03-31 |
1994-10-13 |
Sterling Winthrop Inc. |
Oligonucleotides with amide linkages replacing phosphodiester linkages
|
|
US5342781A
(en)
|
1993-07-15 |
1994-08-30 |
Su Wei Wen W |
External-loop perfusion air-lift bioreactor
|
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
US5830760A
(en)
|
1993-07-28 |
1998-11-03 |
Fred Hutchinson Cancer Research Center |
Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors
|
|
US5504103A
(en)
|
1993-08-25 |
1996-04-02 |
Eli Lilly And Company |
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
US5789543A
(en)
|
1993-12-30 |
1998-08-04 |
President And Fellows Of Harvard College |
Vertebrate embryonic pattern-inducing proteins and uses related thereto
|
|
US5599705A
(en)
|
1993-11-16 |
1997-02-04 |
Cameron; Robert B. |
In vitro method for producing differentiated universally compatible mature human blood cells
|
|
WO1995015972A1
(en)
|
1993-12-09 |
1995-06-15 |
Thomas Jefferson University |
Compounds and methods for site-directed mutations in eukaryotic cells
|
|
US6384192B1
(en)
|
1993-12-30 |
2002-05-07 |
President & Fellows Of Harvard College |
Vertebrate embryonic pattern-inducing proteins
|
|
US6261786B1
(en)
|
1993-12-30 |
2001-07-17 |
Imperial Cancer Res. Technology |
Screening assays for hedgehog agonists and antagonists
|
|
US6165747A
(en)
|
1993-12-30 |
2000-12-26 |
President & Fellows Of Harvard College |
Nucleic acids encoding hedgehog proteins
|
|
JPH09511392A
(en)
|
1994-02-09 |
1997-11-18 |
ユニシン・テクノロジーズ・インコーポレーテッド |
High performance cell culture bioreactor and method
|
|
US5631219A
(en)
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
|
CA2162465A1
(en)
|
1994-03-11 |
1995-09-14 |
Craig Sandstrom |
Flow-through bioreactor with grooves for cell retention
|
|
US5625050A
(en)
|
1994-03-31 |
1997-04-29 |
Amgen Inc. |
Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
|
|
US5489304A
(en)
|
1994-04-19 |
1996-02-06 |
Brigham & Women's Hospital |
Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
|
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
|
US5770378A
(en)
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
|
US5736396A
(en)
|
1995-01-24 |
1998-04-07 |
Case Western Reserve University |
Lineage-directed induction of human mesenchymal stem cell differentiation
|
|
US5741899A
(en)
|
1995-02-02 |
1998-04-21 |
Cell Genesys, Inc. |
Chimeric receptors comprising janus kinase for regulating cellular pro liferation
|
|
US5716616A
(en)
|
1995-03-28 |
1998-02-10 |
Thomas Jefferson University |
Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
|
|
US5733541A
(en)
|
1995-04-21 |
1998-03-31 |
The Regent Of The University Of Michigan |
Hematopoietic cells: compositions and methods
|
|
US5925567A
(en)
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
|
US5674750A
(en)
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
|
US6680166B1
(en)
|
1995-06-07 |
2004-01-20 |
Claudy Jean Paul Mullon |
Dual fiber bioreactor
|
|
US5728581A
(en)
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
|
US5712154A
(en)
|
1995-06-07 |
1998-01-27 |
W.R. Grace & Co.-Conn. |
Dual fiber bioreactor
|
|
US6306575B1
(en)
|
1995-06-16 |
2001-10-23 |
Stemcell Technologies, Inc. |
Methods for preparing enriched human hematopoietic cell preparations
|
|
US5730753A
(en)
|
1995-07-28 |
1998-03-24 |
Apls Co., Ltd. |
Assembly for adjusting pricking depth of lancet
|
|
US5652356A
(en)
|
1995-08-17 |
1997-07-29 |
Hybridon, Inc. |
Inverted chimeric and hybrid oligonucleotides
|
|
US6117850A
(en)
|
1995-08-28 |
2000-09-12 |
The Collaborative Group, Ltd. |
Mobilization of peripheral blood precursor cells by β(1,3)-glucan
|
|
US6008204A
(en)
|
1995-09-01 |
1999-12-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
US5776699A
(en)
|
1995-09-01 |
1998-07-07 |
Allergan, Inc. |
Method of identifying negative hormone and/or antagonist activities
|
|
US6218128B1
(en)
|
1997-09-12 |
2001-04-17 |
Allergan Sales, Inc. |
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
|
|
US5952345A
(en)
|
1995-09-01 |
1999-09-14 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
US5958954A
(en)
|
1995-09-01 |
1999-09-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
US6329169B1
(en)
|
1995-09-29 |
2001-12-11 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding cytostatin II
|
|
FR2739777B1
(en)
|
1995-10-11 |
1997-11-14 |
Cird Galderma |
LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
|
|
CA2247926A1
(en)
|
1996-03-01 |
1997-09-04 |
Imclone Systems Incorporated |
Use of delta-like protein to inhibit the differentiation of stem cells
|
|
US5877207A
(en)
|
1996-03-11 |
1999-03-02 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
JP2000507812A
(en)
|
1996-03-12 |
2000-06-27 |
ライフ テクノロジーズ，インコーポレイテッド |
Hematopoietic cell culture nutrient supplement
|
|
US6043092A
(en)
|
1996-03-18 |
2000-03-28 |
University Of Pittsburgh |
Cell culture media for mammalian cells
|
|
US5945309A
(en)
|
1996-03-19 |
1999-08-31 |
Human Genome Sciences, Inc. |
Cytostatin III nucleic acids encoding
|
|
TW442459B
(en)
|
1996-04-15 |
2001-06-23 |
Hoffmann La Roche |
Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
|
|
US6455678B1
(en)
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
|
WO1997041209A1
(en)
|
1996-04-29 |
1997-11-06 |
Leuven Research & Development Vzw |
Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
|
|
US5851984A
(en)
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
|
US6130230A
(en)
|
1996-08-28 |
2000-10-10 |
Institut National De La Sante Et De La Recherche Medicale |
Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
|
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
|
AU731937B2
(en)
|
1996-12-10 |
2001-04-05 |
Hadasit Medical Research Services & Development Company Ltd |
Serum-derived factor inducing cell differentiation and medical uses thereof
|
|
US6335195B1
(en)
|
1997-01-28 |
2002-01-01 |
Maret Corporation |
Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
|
|
CA2196496A1
(en)
|
1997-01-31 |
1998-07-31 |
Stephen William Watson Michnick |
Protein fragment complementation assay for the detection of protein-protein interactions
|
|
US6294330B1
(en)
|
1997-01-31 |
2001-09-25 |
Odyssey Pharmaceuticals Inc. |
Protein fragment complementation assays for the detection of biological or drug interactions
|
|
US20030215445A1
(en)
|
1997-05-23 |
2003-11-20 |
Ginette Serrero |
Methods and compositions for inhibiting the growth of hematopoietic malignant cells
|
|
US6372473B1
(en)
|
1997-05-28 |
2002-04-16 |
Human Genome Sciences, Inc. |
Tissue plasminogen activator-like protease
|
|
CA2295474A1
(en)
|
1997-07-08 |
1999-01-21 |
Human Genome Sciences, Inc. |
123 human secreted proteins
|
|
IT1293827B1
(en)
|
1997-08-07 |
1999-03-10 |
Dompe Spa |
METHOD FOR EX VIVO EXPANSION OF HEMATOPOIETIC STEM CELLS
|
|
US6440734B1
(en)
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
|
FR2769491B1
(en)
|
1997-10-15 |
2000-01-07 |
Patrick Sangouard |
ADJUSTABLE ARTIFICIAL SPHINCTER WITH MAGNETIC CONTROL
|
|
CN1511519A
(en)
|
1997-11-12 |
2004-07-14 |
- |
Therapy for immunological disease of type 2 T auxiliary cell mediated
|
|
US6248587B1
(en)
|
1997-11-26 |
2001-06-19 |
University Of Southern Cailfornia |
Method for promoting mesenchymal stem and lineage-specific cell proliferation
|
|
CA2320073C
(en)
|
1998-02-17 |
2011-11-01 |
Gamida Cell Ltd. |
Method of controlling proliferation and differentiation of stem and progenitor cells
|
|
US6962698B1
(en)
|
1998-02-17 |
2005-11-08 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
|
US6886568B2
(en)
|
1998-04-08 |
2005-05-03 |
The Johns Hopkins University |
Method for fabricating cell-containing implants
|
|
US6413773B1
(en)
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
|
CA2330190C
(en)
|
1998-06-08 |
2009-12-22 |
Osiris Therapeutics, Inc. |
Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
|
|
AU4336599A
(en)
|
1998-06-08 |
1999-12-30 |
Osiris Therapeutics, Inc. |
(in vitro) maintenance of hematopoietic stem cells
|
|
US6284540B1
(en)
|
1998-09-29 |
2001-09-04 |
Washington University |
Artemin, a novel neurotrophic factor
|
|
IL142094A0
(en)
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
CA2254429A1
(en)
|
1998-11-19 |
2000-05-19 |
Tully Michael Underhill |
Compositions for promoting chondrogenesis
|
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
|
DE60043534D1
(en)
|
1999-02-04 |
2010-01-28 |
Pluristem Ltd |
METHOD AND DEVICE FOR STABILIZING AND EXPANSIONING HEMATOPOIETIC STEM CELLS AND / OR PRE-CELL CELLS
|
|
CA2372053C
(en)
|
1999-04-28 |
2008-09-02 |
Board Of Regents, The University Of Texas System |
Compositions and methods for cancer treatment by selectively inhibiting vegf
|
|
DE19919242A1
(en)
|
1999-04-28 |
2000-11-02 |
Creavis Tech & Innovation Gmbh |
Modular cell support systems for three-dimensional cell growth
|
|
WO2000073421A2
(en)
|
1999-06-02 |
2000-12-07 |
Lifebank Services, L.L.C. |
Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
|
|
US6652872B2
(en)
|
1999-07-06 |
2003-11-25 |
Ramat At Tel Aviv University Ltd. |
Scaffold formed of tissue treated to eliminate cellular and cytosolic elements
|
|
US20020159984A1
(en)
|
1999-11-12 |
2002-10-31 |
Quality Biological, Inc. |
Cultivation of cells for long term engraftment
|
|
US6541249B2
(en)
|
1999-12-22 |
2003-04-01 |
Human Genome Sciences, Inc. |
Immortalized human stromal cell lines
|
|
US6303374B1
(en)
|
2000-01-18 |
2001-10-16 |
Isis Pharmaceuticals Inc. |
Antisense modulation of caspase 3 expression
|
|
AU2001268255A1
(en)
|
2000-06-05 |
2001-12-17 |
The Burnham Institute |
Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
|
|
IL154159A0
(en)
|
2000-08-01 |
2003-07-31 |
Yissum Res Dev Co |
Directed differentiation of ebryonic cells
|
|
US7198940B2
(en)
|
2000-10-25 |
2007-04-03 |
Shot Hardware Optimization Technology, Inc. |
Bioreactor apparatus and cell culturing system
|
|
ES2171131B1
(en)
|
2000-11-10 |
2003-12-16 |
Idebio S L |
QUITOSANE BASED BIOLOGICAL PESTICIDE
|
|
US6642019B1
(en)
|
2000-11-22 |
2003-11-04 |
Synthecan, Inc. |
Vessel, preferably spherical or oblate spherical for growing or culturing cells, cellular aggregates, tissues and organoids and methods for using same
|
|
WO2002064755A2
(en)
|
2001-02-14 |
2002-08-22 |
Anthrogenesis Corporation |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
|
CA2442177A1
(en)
|
2001-03-29 |
2002-10-10 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
|
|
AU2002308637B2
(en)
|
2001-05-11 |
2007-05-17 |
Board Of Regents, The University Of Texas System |
Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
|
|
US20030017134A1
(en)
|
2001-06-19 |
2003-01-23 |
Technion Research And Development Foundation Ltd. |
Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
|
|
DE10131388B4
(en)
|
2001-06-28 |
2004-07-08 |
Infineon Technologies Ag |
Integrated dynamic memory and method for operating the same
|
|
CA2351156A1
(en)
|
2001-07-04 |
2003-01-04 |
Peter W. Zandstra |
A bioprocess for the generation of pluripotent cell derived cells and tissues
|
|
EP1424389A4
(en)
|
2001-08-07 |
2004-08-25 |
Kirin Brewery |
Process for preparing hematopoietic stem cells
|
|
AU2002349912A1
(en)
|
2001-10-24 |
2003-05-06 |
Iconix Pharmaceuticals, Inc. |
Modulators of phosphoinositide 3-kinase
|
|
US6887401B2
(en)
|
2001-11-05 |
2005-05-03 |
Essilor International Compagnie General D'optique |
Method for making transparent polythiourethane substrates in particular optical substrates
|
|
AUPR892501A0
(en)
|
2001-11-16 |
2001-12-13 |
Peter Maccallum Cancer Institute, The |
Method of enhancing self renewal of stem cells and uses thereof
|
|
US20050095228A1
(en)
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
US7514075B2
(en)
|
2001-12-07 |
2009-04-07 |
Cytori Therapeutics, Inc. |
Systems and methods for separating and concentrating adipose derived stem cells from tissue
|
|
DE10162814B4
(en)
|
2001-12-19 |
2005-06-23 |
Henkel Kgaa |
Reconstructed hair follicle model
|
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
|
PE20030968A1
(en)
|
2002-02-28 |
2004-01-12 |
Novartis Ag |
DERIVATIVES OF 5-PHENYLTIAZOLE AS KINASE INHIBITORS
|
|
AU2003214614B2
(en)
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
US7247477B2
(en)
|
2002-04-16 |
2007-07-24 |
Technion Research & Development Foundation Ltd. |
Methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
|
|
EP1534820A4
(en)
|
2002-08-19 |
2006-04-26 |
Gamida Cell Ltd |
Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures
|
|
US20050054097A1
(en)
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
|
US7470538B2
(en)
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
EP1601759A4
(en)
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
|
US20040247574A1
(en)
|
2003-05-27 |
2004-12-09 |
Christopherson Kent W. |
Methods for enhancing stem cell engraftment during transplantation
|
|
IL161903A0
(en)
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
|
WO2005007799A2
(en)
|
2003-07-17 |
2005-01-27 |
Gamida-Cell Ltd. |
Methods for ex-vivo expanding stem/progenitor cells
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US20050260748A1
(en)
|
2004-02-27 |
2005-11-24 |
Michigan State University |
Adult stem cells and uses thereof
|
|
WO2005086845A2
(en)
|
2004-03-10 |
2005-09-22 |
Regents Of The University Of California |
Compositions and methods for growth of embryonic stem cells
|
|
WO2006030442A2
(en)
*
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
|
EP1809738B1
(en)
|
2004-11-02 |
2014-03-05 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Compositions and methods for treating hyperproliferative disorders
|
|
MX2007009173A
(en)
|
2005-01-31 |
2008-03-10 |
Cognate Therapeutics Inc |
Adipose derived adult stromal cells exhibiting characteristics of endothelial cells.
|
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
|
BRPI0620523A2
(en)
|
2005-11-29 |
2011-11-16 |
Gamida Cell Ltd |
method of increasing implant potential and cell attraction, method of preparing cells for transplantation in a subject, cell population and pharmaceutical composition
|
|
WO2007066338A1
(en)
|
2005-12-08 |
2007-06-14 |
Ramot At Tel Aviv University Ltd. |
Isolated oligodendrocyte-like cells and populations comprising same for the treatment of cns diseases
|
|
JP2010500047A
(en)
|
2006-08-15 |
2010-01-07 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
Mesenchymal stem cell conditioned medium
|
|
US20080199441A1
(en)
|
2006-11-09 |
2008-08-21 |
Tony Peled |
Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
|
|
KR100995835B1
(en)
|
2007-12-18 |
2010-11-23 |
동국대학교 산학협력단 |
Method for preparation of hepatocytes with liver-specific functions using mesenchymal stem cells and umbilical cord-derived hepatocytes prepared thereby
|
|
US20090257987A1
(en)
|
2008-04-10 |
2009-10-15 |
Ramot At Tel Aviv University Ltd. |
Method of generating dopamine-secreting cells
|
|
US8062632B2
(en)
|
2008-06-23 |
2011-11-22 |
National Yang-Ming University |
Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof
|
|
TWI397585B
(en)
|
2008-07-16 |
2013-06-01 |
Univ Nat Taiwan |
Cell culture method and application thereof
|
|
GB0818725D0
(en)
|
2008-10-13 |
2008-11-19 |
Habib Nagy A |
Pharmaceutical composition
|
|
PE20100362A1
(en)
|
2008-10-30 |
2010-05-27 |
Irm Llc |
PURINE DERIVATIVES THAT EXPAND HEMATOPOYETIC STEM CELLS
|
|
JP5606008B2
(en)
|
2009-04-13 |
2014-10-15 |
三菱重工業株式会社 |
Method for culturing bone marrow stromal cells and mesenchymal stem cells, method for producing transplanted cells for treatment of central nervous system diseases
|
|
EP2333047A1
(en)
|
2009-12-09 |
2011-06-15 |
Fresenius Medical Care Deutschland GmbH |
Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
|
|
CA2785627C
(en)
|
2009-12-29 |
2020-02-18 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
|
KR101859124B1
(en)
*
|
2010-05-03 |
2018-05-21 |
더 텍사스 에이 & 엠 유니버시티 시스템 |
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
|
|
AU2013219945B2
(en)
|
2012-02-13 |
2017-12-07 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|